Cardiovascular prostheses
First Claim
Patent Images
1. A vascular graft for treating damaged or diseased tissue, comprising:
- a sheet member comprising top and bottom surfaces, and an outer coating layer disposed on said sheet member top surface, said outer coating layer comprising poly(glycerol sebacate) (PGS),said sheet member consisting of an exosome augmented composition consisting of acellular ECM derived from mammalian tissue source selected from the group consisting of small intestine submucosa (SIS), mesothelial tissue, placental tissue and cardiac tissue and a plurality of exogenous exosomes derived from mesenchymal stem cells (MSCs),said sheet member, when disposed proximate damaged tissue, being adapted to reduce an inflammatory phase of said damaged tissue and, thereby, reduce an inflammatory response thereof, whereby said sheet member induces enhanced, stem cell proliferation, neovascularization, remodeling of said damaged tissue, and regeneration of new tissue and tissue structures with site specific structural and functional properties, compared to induced stem cell proliferation, neovascularization, remodeling, and regeneration of new tissue and tissue structures by an ECM sheet member consisting solely of acellular mammalian ECM,said coated top surface of said sheet member, when disposed proximate said damaged tissue, being adapted to adhere to said damaged tissue, degrade and exhibit a linear degradation profile.
7 Assignments
0 Petitions
Accused Products
Abstract
Cardiovascular prostheses for treating, reconstructing and replacing damaged or diseased cardiovascular tissue that are formed from acellular extracellular matrix (ECM). The cardiovascular prostheses comprise various compositions, such as ECM based compositions, and structures, such as particulate structures, mesh constructs, encasement structures, coated structures and multi-sheet laminate structures.
4 Citations
1 Claim
-
1. A vascular graft for treating damaged or diseased tissue, comprising:
-
a sheet member comprising top and bottom surfaces, and an outer coating layer disposed on said sheet member top surface, said outer coating layer comprising poly(glycerol sebacate) (PGS), said sheet member consisting of an exosome augmented composition consisting of acellular ECM derived from mammalian tissue source selected from the group consisting of small intestine submucosa (SIS), mesothelial tissue, placental tissue and cardiac tissue and a plurality of exogenous exosomes derived from mesenchymal stem cells (MSCs), said sheet member, when disposed proximate damaged tissue, being adapted to reduce an inflammatory phase of said damaged tissue and, thereby, reduce an inflammatory response thereof, whereby said sheet member induces enhanced, stem cell proliferation, neovascularization, remodeling of said damaged tissue, and regeneration of new tissue and tissue structures with site specific structural and functional properties, compared to induced stem cell proliferation, neovascularization, remodeling, and regeneration of new tissue and tissue structures by an ECM sheet member consisting solely of acellular mammalian ECM, said coated top surface of said sheet member, when disposed proximate said damaged tissue, being adapted to adhere to said damaged tissue, degrade and exhibit a linear degradation profile.
-
Specification